Chat OEC
Company Explorer
Trend Explorer
Tree map
Stacked
Network
Map
Scatter
Exports In 2022, Japan exported $3.9B in Vaccines, blood, antisera, toxins and cultures, making it the 15th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 38th most exported product in Japan. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Japan are: United States ($1.53B), Switzerland ($1.17B), Germany ($257M), United Kingdom ($157M), and South Korea ($128M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Japan between 2021 and 2022 were Switzerland ($195M), United States ($160M), and Kuwait ($33.7M).
Imports In 2022, Japan imported $19.6B in Vaccines, blood, antisera, toxins and cultures, becoming the 4th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Japan. Japan imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($6.02B), United States ($3.11B), Switzerland ($3.04B), Spain ($2.71B), and Germany ($1.5B).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Japan between 2021 and 2022 were Spain ($2.42B), Belgium ($1.33B), and Switzerland ($929M).
COMPANIES In 2023, leading companies such as Tesla (3) and Wismettac Asian Foods (2) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Japan to the United States.
